---
figid: PMC4107319__nihms-606697-f0008
figtitle: GIV/Girdin is a central hub for pro-fibrogenic signalling networks during
  liver fibrosis
organisms:
- NA
pmcid: PMC4107319
filename: nihms-606697-f0008.jpg
figlink: /pmc/articles/PMC4107319/figure/F8/
number: F8
caption: Ligand stimulation of diverse classes of fibrogenic receptors (top) converge
  upon GIV either via direct interaction (solid arrow) or via unknown mechanism (interrupted
  arrow) to enhance PI3K-Akt signaling (1) and activate trimeric Gαi (2). GIV-dependent
  activation of Akt elicits several non-transcriptional responses (3) that lead into
  activation of HSCs. The GIV-PI3K-Akt pathway also modulates two distinct transcriptional
  programs-- (i) Potentiation of the profibrotic TGFβ-SMAD pathway by increasing phosphorylation
  of SMAD2/3 (4) and its translocation into the nucleus (5), and thereby, enhancing
  proliferation and transcription of collagen and α-SMA (6); (ii) Inhibition of the
  transcription factor Foxo1 by phosphorylation (7) and by triggering its translocation
  outside the nucleus (8), thereby antagonizing the anti-fibrotic program (9) that
  Foxo1 maintains in physiology. Activation of Gi by GIV's GEF function (2) inhibits
  the production of cAMP (10), a major anti-fibrotic pathway in HSCs by virtue of
  its ability to inhibit HSC migration and proliferation (11). The cAMP-PKA pathway
  is also known to inhibit fibrosis at a transcriptional level by phosphorylating
  CREB (12) which translocates to the nucleus and inhibits transcription of collagen
  and α-SMA (13). Pro-fibrogenic pathways = blue; Anti-fibrogenic = red.
papertitle: GIV/Girdin is a central hub for pro-fibrogenic signalling networks during
  liver fibrosis.
reftext: Inmaculada Lopez-Sanchez, et al. Nat Commun. 2014;5:4451-4451.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9661994
figid_alias: PMC4107319__F8
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4107319__F8
ndex: 1f705258-ded0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4107319__nihms-606697-f0008.html
  '@type': Dataset
  description: Ligand stimulation of diverse classes of fibrogenic receptors (top)
    converge upon GIV either via direct interaction (solid arrow) or via unknown mechanism
    (interrupted arrow) to enhance PI3K-Akt signaling (1) and activate trimeric Gαi
    (2). GIV-dependent activation of Akt elicits several non-transcriptional responses
    (3) that lead into activation of HSCs. The GIV-PI3K-Akt pathway also modulates
    two distinct transcriptional programs-- (i) Potentiation of the profibrotic TGFβ-SMAD
    pathway by increasing phosphorylation of SMAD2/3 (4) and its translocation into
    the nucleus (5), and thereby, enhancing proliferation and transcription of collagen
    and α-SMA (6); (ii) Inhibition of the transcription factor Foxo1 by phosphorylation
    (7) and by triggering its translocation outside the nucleus (8), thereby antagonizing
    the anti-fibrotic program (9) that Foxo1 maintains in physiology. Activation of
    Gi by GIV's GEF function (2) inhibits the production of cAMP (10), a major anti-fibrotic
    pathway in HSCs by virtue of its ability to inhibit HSC migration and proliferation
    (11). The cAMP-PKA pathway is also known to inhibit fibrosis at a transcriptional
    level by phosphorylating CREB (12) which translocates to the nucleus and inhibits
    transcription of collagen and α-SMA (13). Pro-fibrogenic pathways = blue; Anti-fibrogenic
    = red.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - PDGFRB
  - PDGFRA
  - TLR4
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - CCDC88A
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - MTG1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - FOXO1
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - SMN1
  - Ser
  - Thr
---
